|
C8ORF44 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.91769999996683E-07 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.23139999999677E-06 |
| Normal-vs-Stage2 |
1.642780E-03 |
| Normal-vs-Stage3 |
4.35669999998556E-06 |
| Normal-vs-Stage4 |
3.022700E-03 |
| Stage1-vs-Stage2 |
9.157800E-01 |
| Stage1-vs-Stage3 |
1.811820E-01 |
| Stage1-vs-Stage4 |
8.607600E-01 |
| Stage2-vs-Stage3 |
3.145600E-01 |
| Stage2-vs-Stage4 |
8.287000E-01 |
| Stage3-vs-Stage4 |
5.831200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.85919999956741E-07 |
| Normal-vs-AfricanAmerican |
3.606100E-02 |
| Normal-vs-Asian |
3.177500E-03 |
| Caucasian-vs-AfricanAmerican |
3.492600E-01 |
| Caucasian-vs-Asian |
3.455800E-01 |
| AfricanAmerican-vs-Asian |
8.281000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.551700E-04 |
| Normal-vs-Female |
1.69480000034028E-07 |
| Male-vs-Female |
5.215800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.72027999999491E-05 |
| Normal-vs-Age(41-60Yrs) |
4.57440000001252E-06 |
| Normal-vs-Age(61-80Yrs) |
5.208000E-04 |
| Normal-vs-Age(81-100Yrs) |
1.72290000000075E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.776000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.713600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.371900E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.380800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.477000E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.182200E-03 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.792100E-04 |
| Classical-VS-Follicular |
5.068200E-01 |
| Classical-VS-Other |
9.843600E-01 |
| Classical-VS-Normal |
3.18020000000807E-06 |
| Tall-VS-Follicular |
1.277640E-03 |
| Tall-VS-Other |
9.506500E-02 |
| Tall-VS-Normal |
4.71309999916514E-08 |
| Follicular-VS-Other |
8.540000E-01 |
| Follicular-VS-Normal |
1.939150E-03 |
| Other-VS-Normal |
1.122150E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.33969999996475E-06 |
| Normal-vs-N1 |
2.472300E-02 |
| N0-vs-N1 |
4.494400E-01 |
|
|
